麻豆视频

The BioFrontiers Institute and the Colorado European Union Center of Excellence (CEUCE) are collaborated on opportunities to send an undergraduate student to a research conference, workshop or laboratory in the European Union. CEUCE priorities are to provide students the opportunity to visit Europe to gain a first-hand appreciation of science in the EU. The student鈥檚 research area must be within the mission of the BioFrontiers Institute. CEUCE aims to expand the reach of the EU Centers Program to the dynamic and growing Mountain West region. On campus, the center supports the development of new courses and enrichment of existing courses to bring EU and transatlantic topics into the undergraduate and graduate curricula. Offering fellowships, internships, and research grants, CEUCE strives to create opportunities for students outside of the classroom.

The Evan & Cynthia Jones Graduate Fellowship provides support for top first-year graduate students pursuing doctorates in STEM fields with the IQ Biology certificate program through 2019. Evan Jones founded jVEN Capital, LLC, in July 2007 and serves as its Managing Member. Mr. Jones has 25 years of operating and investment experience in the life sciences industry where he founded or helped start numerous life sciences companies. He currently serves as a Director of OpGen, Inc. and Veracyte, Inc. He has been a Director of Digene since July 1990. He has been a Director of CAS Medical Systems Inc., since May 2008. He serves as Chairman of the Campaign for Public Health. He is a Member of the Board of Directors of the Children鈥檚 Research Institute at the Children鈥檚 National Medical Center and the Board of Visitors of the University of Maryland College of Life Sciences. Mr. Jones received a BA in Biochemistry from the University of Colorado and an M.B.A. from Wharton School at University of Pennsylvania.

David Goeddel provided direct support to cover the stipend, tuition and fees for an IQ Biology graduate student. Goeddel is a pioneer of the biotechnology industry who, employed at the time by Genentech, successfully used genetic engineering to coax bacteria into creating synthetic human insulin, human growth hormone, and human TPA for use in therapeutic medicine. Besides being perhaps the single most important contributor to Genentech's rise to one of the nation's premier biotech companies, his extraordinary drive and competitive work ethic embodied Genentech's early "Clone or Die" culture. Together with Steve McKnight and Robert Tjian, he founded Tularik in 1991, and was President and CEO until Tularik was acquired by Amgen for $1.3 billion in 2004. He is a member of the National Academy of Sciences, a recipient of the Eli Lilly Award in Biological Chemistry and the Scheele Medal from the Swedish Academy of Pharmaceutical Sciences. David earned a B.S. in Chemistry from the University of California, San Diego, and a PhD in Biochemistry from the University of Colorado, Boulder.

The Integrative Graduate Education and Research Traineeship Program (IGERT) is a leading interdisciplinary training program from the National Science Foundation. Three million dollars was awarded to IQ Biology to fund the program from 2011 to 2018. The National Science Foundation created the IGERT program in response to the 1995 National Academy of Science鈥檚 Committee on Science, Engineering, and Public Policy report and the Graduate Education and Postdoctoral Training in the Mathematical and Physical Sciences. Based on their recommendations, the program encompasses a more flexible interdisciplinary option for students, increases participation from women and underrepresented minorities in science and engineering research, and provides students with a breadth of professional and ethical skill set for future careers.